/R E P E A T — Khiron Enters Exclusive Partnership with RAPPI, Latin America’s premier Home Multi-Vertical App Platform/

News supplied by

Share this informative article

• Rappi could be the home that is largest multi-Vertical application in Latin America , which received a USD 1 Billion investment from Softbank Group Corp. and Softbank Vision Fund, reaching unicorn status in 2019. Rappi runs in Brazil , Colombia , Mexico , Argentina , Chile , Costa Rica , Uruguay , Ecuador and Peru , which together represent a population of over 600 million individuals.
• Rappi’s multi-vertical software provides banking that is digital re payment solutions, along with anything from meals to pharmaceutical services and products, customer package products and courier solutions, with on average significantly more than 10 million active users month-to-month, in accordance with research company Apptopia.
• Expansive contract begins by having a 6-month distribution that is exclusive Rappi and Khiron to introduce and circulate the business’s CPG item portfolio across Latin America through the Rappi platform.
• The partnership allows Khiron to introduce its CBD product lines in every country where Rappi has an established presence, leveraging a rapidly growing trend toward online sales and last-mile delivery with the potential for future expansion. The contract is anticipated to cut back product that is overall and, logistics expenses, increasing accessibility and contact with an incredible number of customers, and increasing margins for both events.
• The Kuida TM store that is in-app Rappi was released in Colombia in might 2020 . The businesses want to expand circulation through RappiВґs consumer that is fast growing to Uruguay and Costa Rica , where Kuida happens to be authorized, as well as other nations such as for instance Brazil , Mexico and Chile , susceptible to regulatory approvals.

TORONTO , Sept. 3, 2020 /CNW/ – Khiron Life Sciences Corp. (“Khiron” or perhaps the “Company”) (TSXV: KHRN), (OTCQX: KHRNF), ( Frankfurt : A2JMZC), a vertically incorporated cannabis frontrunner with core operations in Latin America and European countries , announced today so it has entered into a distribution that is exclusive with Rappi SAS, the best Latin American last-mile multi-vertical platform this is certainly supported by having a USD 1 billion investment from Softbank Group Corp., and Softbank Vision Fund. The agreement that is expansive a 6-month exclusive circulation partnership between Rappi and Khiron to introduce and circulate the business’s CPG item portfolio across Latin America through the Rappi platform, you start with Kuida TM , the business’s branded CBD skincare products, aided by the prospective to create on the partnership in the long run.

Beyond a regular merchant agreement, this expanded partnership presents the business’s CBD-based health items to scores of Rappi users across Latin America through its advanced technology and advanced, customer-centric advertising techniques. Aided by the Kuida store currently launched on Rappi in May 2020 when it comes to market that is colombian circulation would be expanded to Uruguay and Costa Rica , where Kuida happens to be recently authorized. The business additionally promises to introduce its manufacturer product line through Rappi’s fast growing customer base to nations such as for instance Brazil , Mexico , Ecuador and Chile , susceptible to regulatory approvals.

Colombia’s Rappi could be the market leading multi-vertical application in Latin America with an existence in Brazil , Colombia , Mexico , Argentina , Chile , Ecuador , Costa Rica , Uruguay and Peru . Through its platform, clients purchase products and solutions and enjoy house distribution across multiple groups, including, medical, wellness, grocery, restaurants, pharmacies, drink and expert solutions amongst others. In addition, the program includes a wallet that is virtual RappiPay TM , where users will make P2P transfers and re re payments. Rappi has on average significantly more than 10 million active users month-to-month, in accordance with research company Apptopia, supplying deliveries for pretty much 100,000 companies in LatAm, including over 13 million deliveries in Colombia alone.

“Rappi may be the distribution brand name that everybody else in Latin America understands and utilizes daily. The partnership with Rappi decreases our item launch and logistics expenses and transforms our supply and visibility to an incredible number of clients throughout the area. Rappi could be the last-mile distribution brand name that can help us bring Khiron item to more clients than previously. Our company is proud to determine this first-of-its-kind partnership between both of these businesses, that are both industry leaders in LatAm, and had been both established by Colombians,” comments Alvaro Torres , Khiron CEO and director.

“Given that marketplace for customer cannabis products globalizes it really is a natural fit for us to partner with Khiron to meet up with our application usersВґ requires. Like us, they truly are an accepted leader in your community, plus an innovator in bringing quality services and products to market, “commentary Simon Borrero , Rappi SAS CEO.

About Khiron Lifestyle Sciences Corp.

Khiron Life Sciences Corp. may be the principal integrated cannabis that are medical in Latin America . Khiron has core operations in Latin America , along side task in united states and European countries , and it is certified in Colombia when it comes to cultivation, manufacturing, domestic circulation, and worldwide export of both tetrahydrocannabinol (THC) and cannabidiol (CBD) medical cannabis. The Company delivers well in course regulatory conformity, is fully authorized to produce and fill prescriptions for high- and low-THC medical cannabis in Colombia and has now 1st approved type of CBD cosmetic services and products on rack in Colombia, and obtainable in the usa plus the uk .

The company combines global scientific expertise, agricultural advantages, branded product market entrance experience and education to drive prescription and brand loyalty to address priority medical conditions such as chronic pain miss travel giriЕџ, epilepsy, depression and anxiety in the Latin American market of over 620 million people with a focused regional strategy and patient oriented approach. The organization is led by Co-founder and ceo, Alvaro Torres , as well as an executive that is experienced, and a qualified Board of Directors that features previous President of Mexico , Vicente Fox .

Cautionary Notes

Forward-Looking Statements

This news release may include specific “forward-looking information” and “forward-looking statements” in the meaning of relevant securities legislation. All information contained herein that isn’t historic in general may represent information that is forward-looking. Khiron undertakes no responsibility to comment analyses, objectives or statements produced by third-parties in respect of Khiron, its securities, or monetary or working outcomes (as relevant). Although Khiron believes that the objectives reflected in forward-looking statements in this pr release are reasonable, such forward-looking declaration has been centered on objectives, factors and presumptions concerning future activities which could end up being inaccurate consequently they are at the mercy of many dangers and uncertainties, specific of that are beyond Khiron’s control, like the danger factors talked about in Khiron’s Annual Information Form which will be available on Khiron’s SEDAR profile at sedar . The forward-looking information contained in this news release is expressly qualified by this cautionary declaration and generally are made at the time of the date hereof. Khiron disclaims any intention and it has no responsibility or duty, except as needed for legal reasons, to update or revise any forward-looking information, whether as a consequence of brand brand brand new information, future events or elsewhere.

Neither the TSXV nor its Regulation Services Provider (as that term is defined within the policies associated with the TSXV) takes obligation for the accuracy or adequacy with this pr release.